Wednesday, August 13, 2008

Update on Nvidia (NVDA) and Long's Drugs (LDG)

A couple of highlights:

1. CVS bought out Long's Drugs. I predicted this would happen on May 29, 2008:

Longs is going to be a good company and attractive takeover target, assuming its insurance company purchase works out. It's too difficult for new entrants to get into the pharmacy business, so there seems to be a wide moat here. Also, no one (except maybe Walgreen's) has the stores in California that Long's has, so CVS is going to be knocking one of these days. As long as anti-trust issues don't harm any possible deal, Longs should be a decent long term investment.

2. NVDA stock increased 10.75% today, one day after I indicated the stock was oversold and bought shares. I sold today, making 8% (I had existing shares bought at higher prices, lowering my gain).

People seemed concerned about NVDA's numbers, and some headlines mention "big quarterly loss" and "disappointing" results. These headlines are overblown. Analysts expected 12 cents a share. If you exclude one-time charges and go with the non-GAAP numbers, NVDA beat earnings and earned a diluted net income of 13 cents per share. See numbers here:

Put simply, I believe the non-GAAP numbers and the share buyback are the reasons for the 10.75% increase today.

No comments: